"This is a UPMC Hillman Cancer Center medical oncology location. Contact us to learn more about medical oncology treatment options."

During the past decade, UPMC Cancer Center at UPMC Northwest conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 38 clinical trials were completed, i.e. on average, 61.3% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 29 clinical trials were completed. i.e. 170.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC Cancer Center at UPMC Northwest" #1 sponsor was "National Cancer Institute (NCI)" with 35 trials, followed by "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "SWOG Cancer Research Network" with 14 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "NRG Oncology" with 7 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Cancer Center at UPMC Northwest" #1 collaborator was "National Cancer Institute (NCI)" with 49 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Radiation Therapy Oncology Group" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Cancer Center at UPMC Northwest" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IIIA Breast Cancer" (6 trials), "Invasive Breast Carcinoma" (5 trials) and "Stage II Breast Cancer" (5 trials). Many other conditions were trialed in "UPMC Cancer Center at UPMC Northwest" in a lesser frequency.

Most popular intervention types in "UPMC Cancer Center at UPMC Northwest" are "Drug" (77 trials), "Other" (58 trials), "Biological" (31 trials), "Radiation" (28 trials) and "Procedure" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (34 trials), "Quality-of-Life Assessment" (22 trials), "Cisplatin" (15 trials), "Carboplatin" (12 trials) and "Computed Tomography" (12 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Cancer Center at UPMC Northwest" are 71 trials for "All" genders, 13 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "UPMC Cancer Center at UPMC Northwest". undefined are not yet recruiting, 21 are recruiting, 39 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in UPMC Cancer Center at UPMC Northwest, 3 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Cancer Center at UPMC Northwest, 0 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".